1. AB0249 Investigating the effect of etanercept on the peripheral B cell compartment in children with juvenile idiopathic arthritis. (23rd January 2014) Authors: Meyer-Bahlburg, A.; Quach, T.; Gläsener, S.; Dressler, F.; Onken, N.; Weller, F.; Huppertz, H.-I.; Thon, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1002 Disease Characteristics and Disease Activity in Enthesitis-Related Arthritis During the First Year of Rheumatology Care – Results from an Inception Cohort Study. (9th June 2015) Authors: Niewerth, M.; Klotsche, J.; Liedmann, I.; Hospach, A.; Horneff, G.; Thon, A.; Huppertz, H.-I.; Kümmerle-Deschner, J.; Sengler, C.; Minden, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0532 Inactive Disease during the First 12 Months after Enrollment – Results from the Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON). (10th June 2014) Authors: Sengler, C.; Niewerth, M.; Klotsche, J.; Liedmann, I.; Huppertz, H.-I.; Foell, D.; Horneff, G.; Foeldvari, I.; Minden, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0217 Adjudication of Infections in The Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (Pharmachild) Treated with Biologic Agents and/or Methotrexate. (15th July 2016) Authors: Swart, J.; Giancane, G.; Bovis, F.; Castagnola, E.; Groll, A.; Horneff, G.; Huppertz, H.-I.; Lovell, D.; Wolfs, T.; Hofer, M.; Alekseeva, E.; Panaviene, V.; Nielsen, S.; Anton, J.; Uettwiller, F.; Stanevicha, V.; Trachana, M.; De Benedetti, F.; Ailioaie, L.M.; Tsitsami, E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0386 Adjudication of infections from the pharmacovigilance in juvenile idiopathic arthritis patients (PHARMACHILD) treated with biologic agents and/or methotrexate: update on results with a focus on opportunistic infections. (12th June 2018) Authors: Giancane, G.; Swart, J.F.; Castagnola, E.; Groll, A.; Horneff, G.; Huppertz, H.-I.; Lovell, D.J.; Wolfs, T.; Hofer, M.; Alexeeva, E.; Panaviene, V.; Nielsen, S.; Antón López, J.; Uettwiller, F.; Staņevicha, V.; Trachana, M.; De Benedetti, F.; Ailioaie, L.M.; Tsitsami, E.; Kamphuis, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0598 Safety of tocilizumab in patients aged <2 years with active systemic juvenile idiopathic arthritis treated for one year. (12th June 2018) Authors: Wimalasundera, S.; Calvo Penades, I.; Cuttica, R.; Huppertz, H.-I.; Joos, R.; Milojevic, D.; Rosenkranz, M.; Schikler, K.; Constantin, T.; Douglass, W.; Wells, C.; Kimura, Y.; Wouters, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗